HomeCancer

Cancer

Plus Therapeutics to Current on the Gordon Analysis Convention Radionuclide Theranostics for the Administration of Most cancers

AUSTIN, Texas, July 02, 2024 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Firm”), a clinical-stage pharmaceutical firm growing focused radiotherapeutics...

Scientific Shows Spotlight OGM’s Utility for Most cancers

At a sponsored workshop, Su Yang from The College of Texas MD Anderson Most cancers Middle will current case research that show the...

2024 UNSW Most cancers Symposium recap

The 2024 UNSW Most cancers Symposium, held on June 13, 2024, introduced collectively 198 attendees, together with most cancers researchers...

Hot Topics